Guangchun Han

18PUBLICATIONS
199CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Liquid biopsiesTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 02, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma.

Ziheng Chen, I-Lin Ho, Jintan Liu

|Nov 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.

Melinda Soeung, Xinmiao Yan, Ciro Zanca

|Jan 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial.

Pavlos Msaouel, Kai Yu, Ying Yuan

|Aug 24, 2024
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics.

Jiahui Jiang, Yunhe Liu, Jiangjiang Qin

|Feb 28, 2024
An atlas of epithelial cell states and plasticity in lung adenocarcinoma.

Guangchun Han, Ansam Sinjab, Zahraa Rahal

|May 29, 2023
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.

Yanshuo Chu, Enyu Dai, Yating Li

Pageof 3

Frequent Collaborators

18 joint publications

Linghua Wang

11 joint publications

P Andrew Futreal

7 joint publications

Shaojun Zhang

6 joint publications

Jianhua Zhang